日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy

多组学分析定义了尿路上皮癌的三种不同的分子亚型,这对精准治疗具有重要意义。

van Creij, Nils C H; Tymoszuk, Piotr; Handle, Florian; Seeber, Andreas; Sellemond, Teresa; Martowicz, Agnieszka; Comperat, Eva; Wafa, Hamed; Ormanns, Steffen; Günther, Michael; Parson, Walther; Noeparast, Maxim; Santer, Frédéric R; Subiela, José Daniel; Grivas, Petros; Li, Roger; Culig, Zoran; Pichler, Renate

Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?

晚期尿路上皮癌肝转移(ARON-2):帕博利珠单抗和阿维鲁单抗在预后不良的情况下是否能起到作用?

Cerbone, Linda; Roviello, Giandomenico; Calabrò, Fabio; Taha, Tarek; Grande, Enrique; Binz, Kirstin; Kanesvaran, Ravindran; Pirstuk, Alina; Fiala, Ondřej; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Rizzo, Alessandro; Pichler, Renate; Myint, Zin W; Poprach, Alexandr; Facchini, Gaetano; Bohuslav, Melichar; Studentova, Hana; Morelli, Franco; Buchler, Tomas; Mennitto, Alessia; Tural, Deniz; Formisano, Luigi; Orejana, Inmaculada; Catalano, Martina; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Gupta, Shilpa; Massari, Francesco; Santoni, Matteo

Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV)

阿维鲁单抗、帕博利珠单抗和恩福妥单抗治疗晚期鳞状分化尿路上皮癌患者的真实世界疗效(ARON-2EV)

Mollica, Veronica; Massari, Francesco; Fujita, Kazutoshi; Giannatempo, Patrizia; Grande, Enrique; Büttner, Thomas; Bourlon, Maria T; Taha, Tarek; Fukuokaya, Wataru; Myint, Zin W; Pichler, Renate; Binz, Kirstin; Molina-Cerrillo, Javier; Kopecky, Jindrich; de Liaño, Alfonso Gómez; Kucharz, Jakub; Fiala, Ondřej; Matrana, Marc R; Kopp, Ray Manneh; Di Civita, Mattia Alberto; Zgura, Anca; Ansari, Jawaher; Kihnel, Randi; De Felice, Francesca; Angel, Martín; Monteiro, Fernando Sabino M; Soares, Andrey; Urun, Yuksel; Buti, Sebastiano; Santini, Daniele; Santoni, Matteo

Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis

恩福妥单抗联合帕博利珠单抗治疗初治转移性尿路上皮癌患者:一项奥地利真实世界分析

Niedersuess-Beke, Dora; Mayrhofer, Karl; Krauter, Johanna; Franke, Johannes; Vais, Dominic; Pallauf, Maximillian; Kiesl, David; Luger, Ferdinand; Pfuner, Jacob; Terbuch, Angelika; Bauernhofer, Thomas; Spielgelberg, Jasmin; Banner, Andreas; Aufderklamm, Stefan; Wiesinger, Clemens; Schnabel, Susanne; Gampenrieder, Simon Peter; Mühlmann, Josef; Vallet, Sonia; Weibrecht, Sabine; Stoiber, Franz; Andalibi, Haleh; Fajkovic, Harun; Taghizadeh, Hossein; Miechowiecki, Jan; Taedcke, Roman; Heintel, Daniel; Shariat, Shahrokh F; Pichler, Martin; Hilbe, Wolfgang; Pichler, Renate

Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a nonlinear modeling approach

肌少症与高危非肌层浸润性膀胱癌复发风险:一种非线性建模方法

Klinglmair, Gerald; Lutz, Maximilian; Telia, Tatia; van Creij, Nils C H; Wafa, Hamed; Tymoszuk, Piotr; Heim, Beatrice; Niedersuess-Beke, Dora; Terbuch, Angelika; Subiela, José Daniel; Del Giudice, Francesco; Mayr, Roman; Luger, Anna; Pichler, Renate

Training the synergy between Bacillus Calmette-Guérin and immune checkpoint-blocking antibodies in bladder cancer

训练卡介苗与免疫检查点阻断抗体在膀胱癌中的协同作用

Pichler, Renate; Thurnher, Martin

Interplay of IL-6, GDF-15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on Survival

IL-6、GDF-15 和肌少症在接受根治性膀胱切除术的膀胱癌患者中的相互作用及其对生存的影响

Engelmann, Simon U; Kasparbauer, Felix; Pickl, Christoph; Del Giudice, Francesco; Haas, Maximilian; Rinderknecht, Emily; Siska, Peter J; Pichler, Renate; Niessen, Christoph; Burger, Maximilian; Gužvić, Miodrag; Mayr, Roman

Editorial: Streamlining drug approvals: addressing policy challenges in genitourinary oncology

社论:简化药物审批流程:应对泌尿生殖系统肿瘤领域的政策挑战

Mantica, Guglielmo; Hsu, Robert; Pichler, Renate; Benjamin, David J

Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis

针对适合铂类化疗的局部晚期或转移性尿路上皮癌患者的新型联合治疗:系统评价和网络荟萃分析

Yanagisawa, Takafumi; Mori, Keiichiro; Matsukawa, Akihiro; Kawada, Tatsushi; Katayama, Satoshi; Laukhtina, Ekaterina; Rajwa, Pawel; Quhal, Fahad; Pradere, Benjamin; Fukuokaya, Wataru; Iwatani, Kosuke; Pichler, Renate; Teoh, Jeremy Yuen-Chun; Moschini, Marco; Krajewski, Wojciech; Miki, Jun; Shariat, Shahrokh F; Kimura, Takahiro

Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

帕博利珠单抗-阿昔替尼与纳武利尤单抗-卡博替尼作为转移性肾细胞癌患者一线治疗的比较:一项回顾性真实世界比较研究(ARON-1)

Santoni, Matteo; Roviello, Giandomenico; Grande, Enrique; De Giorgi, Ugo; Fiala, Ondrej; Seront, Emmanuel; Molina-Cerrillo, Javier; Pichler, Renate; Myint, Zin W; Kucharz, Jakub; Kanesvaran, Ravindran; Büttner, Thomas; Pichler, Martin; Basso, Umberto; Kopecky, Jindrich; Bourlon, Maria T; Cerbone, Linda; Buchler, Tomas; Pinto, Alvaro; de Liaño, Alfonso Gómez; Gianni, Caterina; Zgura, Anca; Rescigno, Pasquale; Ansari, Jawaher; Caffo, Orazio; Küronya, Zsófia; Vitale, Maria Giuseppa; Bhuva, Dipen; Catalano, Martina; Vau, Nuno; Kopp, Ray Manneh; Buti, Sebastiano; Bamias, Aristotelis; Porta, Camillo; Sunela, Kaisa; Massari, Francesco